Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
S1P1 Receptor Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist.
Treatment of Acute Relapses in Multiple Sclerosis.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Multiple Sclerosis: Risk Factors and Their Interactions.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA).
Use and medicalization of marihuana in cancer patients.
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Adverse socioeconomic position during the life course is associated with multiple sclerosis.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Internal jugular vein entrapment in a multiple sclerosis patient.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
[Clinical features of neuromyelitis optica and the distribution of Chinese medical syndrome types: a case report of 63 cases].
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Pages
« first
‹ previous
…
295
296
297
298
299
300
301
302
303
…
next ›
last »